Simulations Plus, Inc. (SLP) Stock

Simulations Plus, Inc. (SLP) is a Technology stock trading at $18.39 (as of 2026-08-20), with a market capitalization of $371.93M and a trailing P/E of 27.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Simulations Plus, Inc. provides software and related services for drug discovery and development, using modeling and simulation to predict molecular and pharmacology properties. Its offerings include products such as GastroPlus, DILIsym, and chemistry- and pharmacokinetics-focused prediction and modeling suites, serving researchers and organizations worldwide.

Understand Simulations Plus, Inc.: how it makes money

Simulations Plus develops drug discovery and development software, including AI and machine learning based tools for simulating absorption and drug interaction, plus mechanistic and quantitative simulation products, and it also delivers services tied to projects.

The profit model combines recurring software revenue (supported by software customer renewal rates) with project based services delivery (tracked by services projects completed), so performance depends on both customer retention and ongoing project activity.

Business quality (Solid): Operating metrics like software renewal rates and services project counts are provided, but the dataset does not include segment-level revenue breakdown for the four official segments, limiting segment clarity.

Bull case

  • Retention strength: Software Customer Renewal Rate Based on Fees is 90.0 percent (and Software Customer Renewal Rate Based on Accounts is 84.0 percent), which supports the recurring component of the business.
  • Ongoing services execution: Services Projects Completed is 201.0 in the latest quarter provided, with a defined services mix (53.0 percent and 25.0 percent for two listed categories).

Bear case

  • Quarterly project and revenue variability risk: Services are tracked by Projects Completed (201.0) and software revenue is reported separately (Software Revenue is 0.01 USD_B), so results can be sensitive to changes in project activity and software revenue timing.
  • Less transparency on segment economics: The dataset does not provide revenue values by the four official segments (Simulations Plus, Cognigen, DILIsym, Lixoft), so investors cannot clearly attribute operating performance to each segment from these facts.
Valuation — source: SEC EDGAR (first-party)
Price$18.39
Market Cap$371.93M
P/E Ratio27.9
EV / EBITDA18.6
Price / Book2.68
Price / Sales4.18
FCF Yield12.0%
DCF Value (model)$13.50
DCF Upside vs Price-26.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$79.18M
Net Margin-81.7%
Revenue Growth (YoY)7.5%
EPS Growth (YoY)-105.4%
FCF Growth (YoY)58.9%
Financial Health — source: SEC EDGAR
Altman Z-Score30.03 (safe)
Valuation vs Sector & Industry
Stock P/E27.9
Sector P/E (Technology)33.9
Industry P/E (Computers)32.1
vs Sector-17.7%
vs Industry-13.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFirst Light Asset Management, LLC ($31.12M)
Institutional Holders Tracked10
Company
SectorTechnology
IndustryComputers
CEOShawn O'Connor
Employees243
CountryUS
IPO Date1997-06-18

Related Companies (Business model: SaaS / Subscription Software (Enterprise); 8 closest by market cap; US-domiciled)

  • OneSpan Inc. (OSPN)
  • Ribbon Communications Inc. (RBBN)
  • Marlin Business Services Corp. (MRLN)
  • Telos Corporation (TLS)
  • SmartRent, Inc. (SMRT)
  • Asure Software, Inc. (ASUR)
  • Unisys Corporation (UIS)
  • Digimarc Corporation (DMRC)
SLP earnings history · SLP institutional & insider holders · SLP KPIs & operating metrics · SLP financials · SLP investor presentations & press releases · SLP SEC filings · SLP peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.